Insider trades

Christopher U. Missling, CEO of Anavex Life Sciences AVXL, has filed 0 purchases and 2 sales on the open market. The latest trade was on 01/06.

Christopher U. Missling

President and CEO
First filing
23/06/30
Trades
23 trades
Buys / sales
0 / 2
12-month net buying
No record
Last trade
01/06

Trading activity

Transactions

Trade type
Open-market sale24/03/2824/04/0173,380 sh$5.11$374,971.8−5.5%
Open-market sale23/06/2823/06/30268,000 sh$7.98$2,138,640−20.8%